Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Artificial Intelligence and Healthcare
    • Consumer-Driven Health Care
      • Affordable Care Act
      • Cost of Healthcare
      • COVID-19 and Public Health
      • Doctors & Hospitals
      • Public Insurance
      • Policy & Legislation
    • Direct Primary Care
    • Health Economics & Costs
      • Drug Prices & Regulations
      • Health Insurance
      • Health Reform
    • Medical Tourism
    • Telemedicine
    • Medicare
      • Single-Payer/Medicare-for-All
  • Goodman Institute
  • Contact
The Goodman Institute Health Blog

Author: Devon Herrick

FDA Looking to Modify Covid Vaccine for Omicron (Only a Year too Late)

Posted on June 29, 2022June 30, 2022 by Devon Herrick

On Tuesday, the Vaccines and Related Biological Products Advisory Committee of the U.S. Food and Drug Administration met to discuss the Covid-19 vaccine booster. The advisory committee was tasked to decide whether to recommend updating the Covid vaccine to contain an Omicron component for booster vaccines in the United States. Public health officials are concerned that the arrival of colder weather than keeps people indoors along with emerging variants could result in a sharp rise in Covid cases.

+

Book: Regulations Hinder Legal Cannabis Suppliers (Just Like Other Industries)

Posted on June 28, 2022 by Devon Herrick

A new book coauthored by two economists explains the economics of legalized marijuana are not very lucrative. The regulations for selling legal weed are so onerous that illegal marijuana sells for half the price of the highly regulated legal product when competing for the same customers. In fact, the regulatory maze is such that in most states where cannabis is legal aspiring distributors hire consultants to assist with the application process. Indeed, the people in the cannabis industry making the most (legal) money are the consultants and lobbyists.

+

A tale of Two Eye Surgeries: Why One Cost Four Times the Other

Posted on June 27, 2022 by Devon Herrick

Danilo Manimtim and his wife Marilou both had cataract surgery in Fresno, California in late 2021 and early 2022, respectively. Manimtim, a retired orthopedic surgeon, calculated that since he had met his deductible, his cost-sharing would amount to about $750. He sought care at an outpatient department of a local hospital. As I’ve often said, if you are physically capable of walking, never, ever seek any kind of care at a hospital. Manimtim failed to realize that his health plan, the California Public Employees’ Retirement System (CalPERS) health plan, uses an innovative system known as reference pricing. Anthem Blue Cross managed the plan for CalPERS.

+

Have a Chronic Disease? There’s a Smartphone App for That

Posted on June 24, 2022 by Devon Herrick

An article in the San Francisco Chronical that was republished in Kaiser Heath News looked at tech firms that monitor chronic conditions remotely. The firms offer both digital or human health coaches to help patients better manage their care. There are approximately 50 different firms designed to help patients adhere to treatment programs or deal with chronic conditions.

+
  • Previous
  • 1
  • …
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • …
  • 173
  • Next

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 36 other subscribers

Popular Topics

©2025 The Goodman Institute Health Blog | Website by Lexicom